Brentuximab meets phase 3 primary endpoint in frontline advanced HLJune 27, 2017Lymphoma & Plasma Cell DisordersHodgkin LymphomaAggressive Lymphomas
New frontline treatments needed for Hodgkin lymphomaJune 22, 2017Lymphoma & Plasma Cell DisordersHodgkin LymphomaAggressive Lymphomas
Severe health conditions decrease among childhood cancer survivorsJune 4, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatricsALLHodgkin LymphomaNon-Hodgkin LymphomaAggressive Lymphomas
Global study reveals healthcare inequity, preventable deathsMay 23, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersRelated IssuesHodgkin Lymphoma
HL survivors should be screened for CAD after chest irradiationMay 11, 2017Lymphoma & Plasma Cell DisordersHodgkin LymphomaAggressive Lymphomas
Novel inhibitor proves ‘potent’ in hematologic malignanciesMay 9, 2017AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAMLALLMyelodysplastic SyndromeHodgkin Lymphoma
EC approves pembrolizumab for cHL patientsMay 8, 2017Lymphoma & Plasma Cell DisordersPharmacyHodgkin LymphomaAggressive Lymphomas
Pembrolizumab could change treatment paradigm, team saysApril 30, 2017Lymphoma & Plasma Cell DisordersHodgkin LymphomaAggressive Lymphomas
ALL, HL guidelines added to radiation therapy resourceApril 22, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersALLHodgkin LymphomaAggressive Lymphomas
Second cancers take greater toll on younger patientsApril 21, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAMLALLHodgkin LymphomaNon-Hodgkin LymphomaAggressive Lymphomas
Cancer risk, burden expected to shift in HIV populationApril 11, 2017Lymphoma & Plasma Cell DisordersHodgkin LymphomaNon-Hodgkin LymphomaAggressive Lymphomas
CHMP recommends drug for relapsed/refractory cHLMarch 25, 2017Lymphoma & Plasma Cell DisordersPharmacyHodgkin LymphomaAggressive Lymphomas
Most blood cancer mutations due to DNA replication errorsMarch 24, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersHodgkin LymphomaNon-Hodgkin LymphomaAggressive Lymphomas
Preterm births more common in cancer survivorsMarch 24, 2017Lymphoma & Plasma Cell DisordersHodgkin LymphomaNon-Hodgkin LymphomaAggressive Lymphomas
Veterans don’t have higher risk of leukemia, lymphomaMarch 15, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersHodgkin LymphomaNon-Hodgkin LymphomaAggressive Lymphomas
